SpaceX Scrubs Starship Test Flight Reschedules for Friday as V3 Debut Approaches Global Worker Confidence Plunges to Historic Low Amid AI Job Disruption Fears Micron Stock Hits Milestone as UBS Sets Ambitious Price Target on Strong Memory Chip Demand Quanta Services PWR Named Among Louis Navelliers Top LongTerm Picks as Analyst Raises Price Target on Strong Q1 Results SP 500 Edges Higher as Technology Rally Powers Gains Despite Energy Drag US and China Trade Rifts Persist After TrumpXi Summit APEC Signals Show MKTW Q1 2026 Earnings Deep EPS Miss Overshadowed by Modest Stock Recovery Twilio Q1 2026 Earnings EPS Surges Past Expectations Stock Declines Despite Beat VTVT Q1 2026 Earnings Massive EPS Surprise Driven by NonRecurring Items Stock Declines New Fortress Energy Q1 2026 Earnings Deep EPS Miss Triggers Sharp Stock Decline Newsmax Inc NMAX Q1 2026 Earnings NarrowerThanExpected Loss Fuels Positive Investor Sentiment TNGX Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline ServiceNow Inc NOW Rises 189 as Stock Approaches Key Resistance Immunome Inc IMNM Edges Higher as Stock Holds Above Key Support Norfolk Southern NSC Edges Higher as Railroad Sector Shows Resilience Cheniere Energy LNG Holds Steady Near Resistance Technical Outlook for LNG Stock Equifax Inc EFX Creeps Higher as Market Awaits Catalysts Wall Street Opens Higher as Iran Concerns Ease AI Optimism Boosts Futures FLNG Q1 2026 Earnings EPS Misses Estimates Amid Challenging LNG Shipping Market GD Culture Group Limited GDC Edges Lower as Stock Hovers Near Key Support FRPT Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges AirJoule Technologies Corporation AIRJ Q1 2026 Earnings Deep Loss Surprises Market Yet Stock Climbs on Strategic Hopes Accelerant Holdings ARX Q1 2026 Earnings EPS Beat Drives Positive Investor Sentiment PLG Q4 2023 Earnings NarrowerThanExpected Loss Amid Exploration Progress Hoyne Bancorp Inc HYNE Q1 2026 Earnings Negative EPS but Stock Rises Modestly ICCM Q1 2026 Earnings EPS Misses Estimates as Losses Widen Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs